文献速递小儿耳鼻咽喉

整合健康维护提醒改善HPV疫苗接种:朝向缩小完成率差异

Integrated Health Maintenance Reminders for Improved HPV Vaccine Administration: Toward Improvements in Completion Disparities.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-01-29

该回顾性前后对照分析纳入2016至2021年启动HPV疫苗系列的9至26岁患者7654例,评估2020年2月实施健康维护提醒(HMR)前后疫苗完成率的变化。结果显示,HMR实施后完成率由37%升至58.9%(提升59.2%,p<.001);黑种患者和≥18岁患者完成率较低,但HMR后显著改善;HMR后年龄≤14岁患者完成 odds 较高。

要点

  • HMR实施后HPV疫苗完成率由37%升至58.9%,提升59.2%(p<.001)。
  • 黑种患者(aOR=0.68;95%CI:0.60,0.70)和≥18岁患者(aOR=0.13;95%CI:0.11,0.15)完成率显著较低。
  • HMR后年龄≤14岁患者完成 odds 较高(aOR=3.54;95%CI:2.91,4.32)。

核心结论

  • 在该单机构研究中,实施HMR与不同年龄和种族组HPV疫苗完成率提高相关。
  • 未来研究应探索在不同医疗环境中实施HMR的障碍。

研究设计与样本

  • 回顾性前后对照分析,研究场所为学术性初级保健机构。
  • 分析2016至2021年启动HPV疫苗系列的9至26岁患者,以2020年2月实施HMR为界划分前后队列。
  • 采用多因素分析估计社会人口学因素与疫苗完成 odds 的关联,并探讨变量交互作用。

主要发现

  • 全队列7654例患者,平均年龄15.8岁,46.7%为男性,50.7%为白种人。
  • 全队列HPV疫苗完成率由HMR前37%升至HMR后58.9%,提升59.2%(p<.001)。
  • 黑种患者(aOR=0.68;95%CI:0.60,0.70)和≥18岁患者(aOR=0.13;95%CI:0.11,0.15)完成疫苗系列的 odds 显著较低;但HMR后这些组别显著改善(p<.001)。
  • HMR后,种族和保险状态与疫苗完成率差异无独立关联,但年龄有独立关联,≤14岁患者完成 odds 较高(aOR=3.54;95%CI:2.91,4.32)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该研究为单机构研究。
  • 原文结论提出未来研究应探索在不同医疗环境中实施HMR的障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effect of a health maintenance reminder (HMR) on human papillomavirus (HPV) vaccine administration and completion across different age, insurance, and race cohorts. STUDY DESIGN: Retrospective pre-post analysis. SETTING: Academic primary care. METHODS: Patients aged 9 to 26 who had initiated the HPV vaccine series from 2016 to 2021 were analyzed, based on current age-based standards. The cohort was divided based on vaccine uptake before and after the implementation of the HMR program in February 2020. The multivariate analysis estimated the odds of vaccine completion based on sociodemographic factors, and variable interactions were investigated to determine independent associations between sociodemographic factors and HMR implementation. RESULTS: There were 7654 individual patients (mean age was 15.8 years; 46.7 were males; and 50.7% were white). HPV vaccine completion rates increased post-HMR implementation by 59.2% (37% pre-, and 58.9% post-HMR; p < .001) in the entire cohort. Overall, black patients (adjusted odds ratio [aOR] = 0.68; 95% confidence interval [CI]: 0.60, 0.70) and patients ≥18 years (aOR = 0.13; 95% CI: 0.11, 0.15) were significantly less likely to complete their vaccine series; however, this improved significantly following HMR in these groups (p < .001). Post-HMR, race, and insurance status were not independently associated with disparate vaccine completion rates, however, age was, and patients ≤14 or younger had higher odds of vaccine completion (aOR = 3.54; 95% CI: 2.91, 4.32). CONCLUSION: The implementation of an HMR was associated with increased HPV vaccine uptake across age and race groups in this single-institution study. Future research should explore barriers to implementing HMRs in different health care settings.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Rames JD, Frisco NA, Jiang R, et al. Integrated Health Maintenance Reminders for Improved HPV Vaccine Administration: Toward Improvements in Completion Disparities. Otolaryngol Head Neck Surg. 2023. PMID: 36939623. doi:10.1002/ohn.242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。